Lidocaine Hydrochloride B. Braun Melsungen

Lidocaine, the active ingredient in Lidocaine Hydrochloride B. Braun Melsungen, is a local anesthetic presented as a sterile solution for epidural, infiltration and intradermal use. It provides rapid, reversible loss of sensation in targeted tissues and is employed in a variety of minor surgical and diagnostic procedures.

GNH USA supplies Lidocaine Hydrochloride B. Braun Melsungen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lidocaine is a local anesthetic used to block nerve conduction in specific procedural settings.

- Epidural anesthesia: provides localized numbness for epidural procedures and obstetric analgesia. - Infiltration anesthesia: numbs tissue for minor surgical, dental or diagnostic interventions. - Intradermal anesthesia: used for superficial skin anesthesia in dermatologic or cosmetic procedures.

Lidocaine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Burning or tingling at the injection site. - Mild dizziness or light‑headedness. - Nausea or a metallic taste. - Transient hypotension. - Localized swelling or erythema.

Serious or Rare Side Effects: - Seizures or convulsions. - Cardiac arrhythmias, including ventricular tachycardia. - Severe hypotension or cardiovascular collapse. - Methemoglobinemia. - Anaphylactic or severe allergic reactions.

When using Lidocaine Hydrochloride, several safety measures should be observed.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular monitoring: observe for signs of arrhythmia or hypotension during and after administration. - Dosage calculation: ensure dose is appropriate for patient weight, site, and intended use. - Use in compromised patients: exercise caution in individuals with liver disease or pre‑existing cardiac conduction disorders. - Concurrent CNS depressants: avoid or closely monitor when combined with other central nervous system depressants. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidocaine can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma lidocaine levels and risk toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise lidocaine concentrations. - Beta‑blockers: may potentiate cardiac depression when used together.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive neuro‑ or cardiotoxic effects. - Diuretics (e.g., furosemide): may alter plasma protein binding, affecting free drug levels. - General anesthetics (e.g., propofol, volatile agents): may enhance central nervous system depression.